What is it about?
This innovative paper explores the aetiology and pathophysiology of melasma. Learn about the melanogenesis process and how micro needling can promote re-balance and regulation. This in-depth article further assesses why micro needling is so effective for this recalcitrant condition and how the application of topical pigment blockers can further enhance treatment outcomes. Clinical studies from Brazil, Italy and Australia prove treatment success and patient satisfaction.
Featured Image
Why is it important?
Recalcitrant melasma is arguably one of the most challenging indications for treatment by aesthetic practitioners. This innovative paper looks to micro needling as an uncommon, but highly successful patient solution. By contrast with many other modalities, micro needling offers safe and effective treatment parameters and protocols without thermolysis or ablation of the skin. This enables safe treatment on all Fitzpatrick skin types and heritages. Micro needling furthermore offers a longer term management of the condition via the release of regulatory growth factors to treat the very source of the issue. Treatment is fast, affordable and comfortable for the patient with no major downtime.
Perspectives
As a micro needling expert, I have seen phenomenal success with the treatment and long term management of melasma. All of my patients report visual correction of this condition upon completion of a treatment programme. Because there is no heat produced during a micro needling procedure and the epidermis remains in-tact, this is a risk-free procedure suitable for all ethnicities. There is no skin I have come across which has not been eligible for such treatment. I encourage patients to enahnce and maintain results with the daily application of topical pigment blockers and sunscreen. About the author: Dr. Andrew R. Christie – Clinical Director & Global Medical Trainer, DermapenWorld Paris based, Dr. Andrew R. Christie is an industry specialist with over 20 years’ experience. Andrew graduated from Macquarie University (Sydney) and the University Of Southampton (U.K.). Having lectured as a skin and micro-needling expert in over 47 countries, Andrew has been invited as a key speaker at the AMWC (Monte Carlo), CCR / FACE / ACE (London), JSAD (Osaka), NCD (Bucharest), AMEC (Paris), SEME (Malaga), MBC (Zagreb), Cosmetic News (Opartja), ILM (Helsinki), AMCSA (Pretoria), AMME (Arachon), FACDC (Johannesburg), MES (Lausanne), ACEDSSA (Cape Town), AesTech (Auckland), Cosmetex (Gold Coast), ASAPs (Hobart), BEA and the Paramedical Conference (Sydney). Andrew has also been a guest lecturer at the Royal Society Of Medicine (London), University Of Tehran (Tehran), VIC University (Melbourne) and the Royal Hayat Hospital (Kuwait City). Andrew has appeared on television, including Aesthetic TV (USA), Fashion TV (Australia), Cosmetic News (Croatia) and in hundreds of interviews across the world as a master-needler and authority on medical aesthetics. As the Global Medical Trainer for Dermapenworld, Andrew is the author of Advanced Innovations With Dermapen. Andrew has also authored three other books on skin needling and written over 500 articles for industry publications and journals. Andrew is a regular judge for the ABIAs in Australia and was awarded the prestigious Educator Of The Year. Andrew has trained over 50,000 practitioners globally.
Corri Matthews
Read the Original
This page is a summary of: Microneedling and melasma: delivering successful patient solutions, Journal of Aesthetic Nursing, September 2017, Mark Allen Group,
DOI: 10.12968/joan.2017.6.7.334.
You can read the full text:
Contributors
The following have contributed to this page
